Opening Lecture
What we know and what we don’t know about Sepsis
Manu Shankar-Hari, London/UK

New Data and latest findings
Chair: Didier Payen, Nice/France and Axel Nierhaus, Hamburg/Germany

Can we improve the microcirculation?
Can Ince, Rotterdam/The Netherlands

Focus on hemodynamics and shock reversal
Konstanty Szuldrzynski, Warsaw/Poland

Acute pancreatitis – results from the Pacific trial
Sebastian Rasch, Munich/Germany

CytoSorb-Therapy in daily routine
Chair: Claus Krenn, Vienna/Austria and Yatin Mehta, Gurgaon/India

The importance of the right timing and dosing
Steffen Mitzner, Rostock/Germany

Liver support on a higher level
János Fazakas, Budapest/Hungary

Hemoadsorption with CytoSorb in PICU
Gabriella Bottari, Rome/Italy

CytoSorb-Therapy in COVID-19 patients
Chair: Manu Malbrain, Gent/Belgium and Ivano Riva, Bergamo/Italy

Latest results from Europe and Asia
Zsolt Molnar, Budapest/Hungary

Lessons learned in ECMO-patients
Tae Song, Chicago/USA

Panel discussion – when and how should we use CytoSorb in severely ill COVID-19 patients?
Manu Malbrain, Ivano Riva, Zsolt Molnar, Axel Nierhaus, Konstanty Szuldrzynski